Interoperability First: BYOT That Works With Any Site, Any Device

“Bring Your Own Tech” (BYOT) only succeeds when sponsors can work with any qualified site on the stack those sites already use. Sites are saturated with tools and logins; imposing new portals or devices increases burden and causes good sites to decline participation.
The solution is vendor-agnostic interoperability: connect to any site’s existing systems and devices, standardize to research models, preserve provenance and auditability, and deliver decision-grade data to EDC/analytics in near real time. Outcome: broader site access without retooling, faster activation and enrollment, fewer reconciliations, shorter LPLV→DBL, and lower risk at inspection.

1) BYOT, Site First: What Sponsors Need to Solve

● Site reality: Every additional login, device, or required training raises burden and dropout risk.
● Sponsor risk: Excluding sites for “wrong” devices shrinks the recruiting pool and back-loads cleanup to database lock.
● What works: Accept the site as it is. Centralize interoperability so you adapt to the site, not the other way around.

2) Regulatory & Quality Frame: What “Good” Looks Like

Ground BYOT in established expectations for research data integrity and digital health technologies (DHTs):
● Provenance & traceability: Defined originators (people/devices/systems), stable identifiers, versioned transformations, complete audit trails.
● Fit-for-purpose: Verification/validation (V&V) by source and pathway; documented performance characteristics and limitations.
● Governance: Access control, change control, anomaly/missingness handling, SOPs, and training.
● Submission readiness: Standards-based outputs suitable for analysis and inspection.

3) Standards that Convert Consumer-Grade Streams to Regulatory-Grade Use

● HL7® FHIR® at intake where feasible (EHRs, connected devices, apps).
● CDISC (ODM/SDTM) for research/analysis and submission readiness.
● Time/unit normalization (time zones, sampling frequencies, units) with versioned mappings.

4) Reference Architecture (Site-Agnostic)

Goal: Any site. Any stack. Zero new burden at the site.

Ingestion & Identity

● Secure ingestion via APIs/gateways/managed file—no new site portal.
● Persist subject/device identity and metadata (firmware, sampling frequency, versions).
Normalization & Mapping
● Normalize clocks/units/frequencies; harmonize schemas; map to CDISC.
● Document every transform with version control for reproducibility.

Quality & Governance

● Automated anomaly detection and confidence rules to route only true exceptions to HITL review.
● Policy-driven missingness handling; full provenance across the pipeline.

Delivery & Monitoring

● Near real-time delivery to EDC, data lakes, and analytics.
● Dashboards for latency, error rates, and drift; reproducible re-runs.

5) Zero New Site Burden (What Sponsors Should Promise)

● No forced device provisioning or extra credentials at the site.
● Sites keep existing EMR/EHR, ePRO/eCOA, EDC, and apps—interoperate centrally.
● Standardized onboarding shortens start-up and reduces training.
● Vendor-agnostic connectors mean sites don’t retool to participate.

6) BYOT Compliance & Quality Checklist (Operational)

● Originator registry covering people, devices, and systems with roles/permissions
● Stable identifiers linking raw data → transforms → eCRF
● End-to-end audit trail (who/what/when/why) for every step and version
● Verification/validation dossier per DHT and per integration path
● Standards mapping (FHIR at intake where feasible; CDISC ODM/SDTM outputs)
● Automated QC with defined confidence rules and HITL criteria
● Change control for device/app/firmware versions with re-validation triggers
● Documented privacy/consent handling aligned to policy and law

7) Outcomes Sponsors Can Expect

● Broader site access & faster enrollment: Stop excluding sites for “wrong” devices; accept what they have.
●Faster start-up, shorter locks: Continuous standardization and QC prevent end-loaded cleanup.
● Lower site burden: Central architecture shoulders mapping, QC, and documentation.
● Inspection-ready: Provenance and versioned transforms reduce audit risk.

8) Implementation Blueprint (Example)

A pragmatic, phase-gated approach sponsors can follow with an interoperability partner:

Define & Design

● Confirm source systems, endpoints, and fitness-for-purpose criteria.
● Select intake paths (FHIR/API/secure file) and target CDISC structures.
● Author/change-control SOPs; define anomaly/HITL criteria.
Configure & Integrate
● Stand up secure ingestion, identity, normalization, and mappings.
● Configure automated QC + confidence rules; wire audit trails and dashboards.
● Dry-run transforms; iterate on QC findings.

Validate & Deploy

● Run pilot data through full pipeline; finalize V&V package.
● Connect EDC/analytics; train study and data teams.
● Approve production runbook with roll-forward plan for additional sites.

(This is a proven implementation pattern, not a mandate to change site tools.)

9) Ask Vendors These Five Questions (to Keep BYOT Truly Site-First)

1. Standards at intake and output: Which FHIR resources and CDISC structures are supported natively? Show live examples.

2. Identity & versioning: How are originators, elements, and transforms versioned and linked end-to-end?

3. QC & HITL: What automated checks run continuously, and when is human review invoked?

4. Validation & audit: What’s in the validation dossier? How are audit trails exposed for inspection?

5. Site onboarding speed: How quickly can you add a new site without new portals or custom code?

10) How Adaptive Clinical Systems “Makes the Problem Go Away”

Adaptive Clinical Systems delivers a vendor-agnostic interoperability platform — the Adaptive eClinical Bus® with DataVIEW®, purpose-built to let sponsors work with any site on the technology they already have, while keeping data compliant, traceable, and analysis-ready.
What Adaptive Clinical Systems brings:
● Any technology, any site: Pre-built, bi-directional connectors across EDC, eCOA/ePRO, CTMS, IRT, EHR/EMR, labs, DHTs, and wearables—plus support for proprietary and point solutions.
● Standards-based by design: FHIR intake where feasible; CDISC ODM/SDTM outputs; time/unit normalization with versioned mappings.
● Quality built-in: Automated anomaly detection, confidence rules, targeted HITL, and complete provenance/audit trails.
● Zero new site burden: No forced portals or devices; sites keep their stack.
● Inspection-ready documentation: Validation packages and operational logs ready for review.
Engagement path
● Readiness review (15 minutes): Current sites, systems, and data sources.
● Integration plan: Confirm intake paths, mappings, QC rules, deliverables.
● Configuration & validation: Set up connectors, normalization, QC, and audit trail; pilot and finalize V&V.
● Go-live & monitoring: Near real-time delivery to EDC/analytics; dashboards for latency, errors, and drift.

Run BYOT without adding site burden. Book a 15-minute consult to align your study design with a truly site-first, vendor-agnostic data strategy.

Get Demo

Conclusion

BYOT expands access and enriches evidence only when sponsors remove the technology barrier for sites. A vendor-agnostic, validated interoperability layer lets you accept the site as-is, standardize once, and deliver regulatory-grade data downstream—without imposing new tools at the point of care. That’s how you widen your site network, move faster, and stay inspection-ready.
[wpb-fmc-floating-menu]

Blog Posts & Resources

[wpb-fmc-floating-menu]